By the definition of k io ; these rates satisfy the principle of detailed balance (see page 10 and the notes of Chap. 1).
Equilibrium Probabilities
We saw above (see page 8) that the equilibrium state of the reaction shown in Fig. 11 .1 is given by
11.2 Probability Density Functions in the Presence of the Inactivated State These probabilities are graphed as functions of the transmembrane potential in Fig. 11 .2. Note that the open probability in equilibrium is quite small; the channel is basically closed for v close to zero and it is inactivated for large values of v.
Probability Density Functions in the Presence of the Inactivated State
When the inactivated state is included in the model, as indicated in Fig. 11 .1, the system governing the associated probability density functions is given by where
Numerical Simulations
Again, we want to compare the solution computed by Monte Carlo simulations based on the stochastic differential equation given in (11.1) and the probability density functions defined by the system (11.3)-(11.5). The numerical results are given in their usual form in Fig. 11 .3. As expected, the histograms computed using Monte Carlo simulations and the numerical solution of the system (11.3)-(11.5) are quite similar. In these computations, the stochastic simulation ran for 100 s, with t D 0:01 ms, and we used the mesh size v D 0:01 in the numerical solution of the system (11.3)-(11.5). It is particularly interesting to see that the tiny boundary layer close to v D 0 for the probability density function of the inactivated state is captured using both the Monte Carlo and the probability density function approaches.
Mutations Affecting the Inactivated State of the Ion Channel
Certain mutations of the sodium channel are known to impair the channel's ability to deactivate. We introduce a mutation severity index and assume that the reaction rates of the mutant are changed such that both the probabilities of moving from . The probability density of the closed state is only shown for v between 0 and 0.1 to magnify very small differences the inactivated to the closed state and from the inactivated to the open state are increased. The effect of these changes will clearly be to lower the probability of the channel being in the inactivated state.
In mathematical terms, we define
where > 1 and where k ic and k io are the wild type reaction rates given by (11.2). It should be noted that the new reaction rates still satisfy the principle of detailed balance. In Fig. 11 .4, we show the equilibrium probability density functions of the open, closed, and inactivated states for the wild type and for three values of the mutation severity index :
A Theoretical Drug for Mutations Affecting the Inactivation
We want to derive a theoretical drug repairing the effect of the mutation described in (11.7). In the Markov model illustrated in Fig. 11 represented in Fig. 11 .5 is characterized by the equations
It is useful to define 
where
We refer to p as the inverse open probability and we note that for the wild type it is given by p D 1 C r oc C r oi :
Open Probability in the Mutant Case
As discussed above, we are interested in understanding how to define a theoretical drug for mutations affecting the inactivation of the ion channel. We assume that the mutation affects the inactivation in a way that reduces the probability of being in the inactivated state. As mentioned above, this can be modeled by increasing the reaction rates from the inactivated state to both the closed and the open states. We assume that
where > 1 is the mutation severity index. This gives
We assume that the reaction rates between the closed and open states are unaffected by the mutation and therefore
Detailed balance dictates that we should have
which holds regardless of the choice of , since the wild type rates satisfy the principle of detailed balance. The inverse open probability in the presence of the mutations is given by
The Open Probability in the Presence of the Theoretical Drug
When the drug given in Fig. 11 .5 is applied, the inverse open probability is
where r cb ; r ib , and r ob are used to characterize the drug. Our aim is to now use these parameters to tune the drug such that
where p is the inverse open probability of the wild type. More precisely, we want to determine the constants r cb ; r ib , and r ob such that
holds for all relevant values of the transmembrane potential v: We observe that if we put r cb D r ob D 0; we obtain the condition r oi .1 C r ib / r oi and therefore we set
We conclude that we can repair the equilibrium state of the mutation completely by applying a drug consisting of a blocker of the inactivated state, provided that the reaction rates of the drug satisfy
where is the severity index of the mutation. This means that we have reduced the problem of finding a drug to a single parameter given by k bi : This remaining degree of freedom will be addressed below.
Probability Density Functions Using the Blocker of the Inactivated State
In Sect. 11.2 above, we derived a system governing the probability density functions of the open, closed, and inactivated states. Here, we want to extend the system to account for the theoretical drug represented by a blocker of the inactivated state. The Markov model of the drug is given in Fig. 11 .6. The drug will completely repair the equilibrium state of the Markov model, provided that (11.8) where is the mutation severity index of the mutation (see (11.7)). The stationary probability density functions of the states in the Markov model of Fig. 11 .6 are governed by the system
(11.10) Fig. 11.6 Markov model of the prototype ion channel with a blocker associated with the inactivated state (11.12) where o ; c ; i ; and b denote the probability density functions of the open, closed, inactivated, and blocked states, respectively, and where the flux terms are given by
The associated model of the wild type is given by
All the reactions rates used in the computations are given in (11.2); the computational domain is given by D OE0; 1 and we used 201 mesh points. In Fig. 11 .7, we show the difference between the open state probability density function of the wild type, denoted by o ; computed by solving the system (11.13)-(11.15), and the mutant where the drug is applied, computed by solving (11.9)-(11.12), denoted by o : The difference is defined by the norm (11.16) where, as usual,
We observe that, as k bi increases, the drug defined by (11.8) completely repairs the effect of the mutation. The images or other third party material in this chapter are included in the work's Creative Commons license, unless indicated otherwise in the credit line; if such material is not included in the work's Creative Commons license and the respective action is not permitted by statutory regulation, users will need to obtain permission from the license holder to duplicate, adapt or reproduce the material.
